Capricor Therapeutics Files 2024 Annual Report
Ticker: CAPR · Form: 10-K · Filed: Mar 26, 2025 · CIK: 1133869
| Field | Detail |
|---|---|
| Company | Capricor Therapeutics, Inc. (CAPR) |
| Form Type | 10-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
CAPR filed its 2024 10-K. Full financials and biz details inside.
AI Summary
Capricor Therapeutics, Inc. filed its 2024 10-K on March 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Nile Therapeutics, Inc. and SMI Products Inc., is focused on pharmaceutical preparations. Key financial data and operational details for the period are presented in this annual report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Capricor Therapeutics' financial performance, business operations, and strategic outlook for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Capricor Therapeutics is subject to significant regulatory, clinical trial, and market risks inherent in drug development and commercialization.
Key Numbers
- 31148320 — Total Assets (Reported for the fiscal year ending December 31, 2024.)
- 45582288 — Total Liabilities (Reported for the fiscal year ending December 31, 2024.)
Key Players & Entities
- CAPRICOR THERAPEUTICS, INC. (company) — Filer
- Nile Therapeutics, Inc. (company) — Former Company Name
- SMI PRODUCTS INC (company) — Former Company Name
- 20241231 (date) — Fiscal Year End
- 20250326 (date) — Filing Date
- 8840 WILSHIRE BLVD (address) — Business and Mail Address
- BEVERLY HILLS (location) — City
- CA (location) — State
- 90211 (zip_code) — Zip Code
- (310) 358-3200 (phone_number) — Business Phone
FAQ
What is Capricor Therapeutics' primary business focus?
Capricor Therapeutics, Inc. is primarily involved in pharmaceutical preparations, as indicated by its Standard Industrial Classification code [2834].
When did Capricor Therapeutics file its 2024 10-K report?
The 10-K report for the fiscal year ending December 31, 2024, was filed on March 26, 2025.
What were the company's total assets as of December 31, 2024?
The company reported total assets of $31,148,320 as of December 31, 2024.
What were the company's total liabilities as of December 31, 2024?
The company reported total liabilities of $45,582,288 as of December 31, 2024.
Has Capricor Therapeutics operated under any previous names?
Yes, Capricor Therapeutics, Inc. was formerly known as Nile Therapeutics, Inc. and SMI Products Inc.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 26, 2025 regarding CAPRICOR THERAPEUTICS, INC. (CAPR).